# Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature

> clinical trial · VERIFIED · 2026-08-27

Status: RECRUITING · Sponsor: John Neoptolemos · Condition: Pancreatic Ductal Adenocarcinoma

- Company: John Neoptolemos
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05314998

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.